Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2)

 ZEP2_HUMAN              Reviewed;        2446 AA.
P31629; Q02646; Q5THT5; Q9NS05;
01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
06-DEC-2005, sequence version 2.
30-AUG-2017, entry version 159.
RecName: Full=Transcription factor HIVEP2;
AltName: Full=Human immunodeficiency virus type I enhancer-binding protein 2;
Short=HIV-EP2;
AltName: Full=MHC-binding protein 2;
Short=MBP-2;
Name=HIVEP2;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-1538.
PubMed=2022670;
Nomura N., Zhao M.-J., Nagase T., Maekawa T., Ishizaki R., Tabata S.,
Ishii S.;
"HIV-EP2, a new member of the gene family encoding the human
immunodeficiency virus type 1 enhancer-binding protein. Comparison
with HIV-EP1/PRDII-BF1/MBP-1.";
J. Biol. Chem. 266:8590-8594(1991).
[2]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PRO-1538.
PubMed=1409593; DOI=10.1073/pnas.89.19.8971;
Van't Veer L.J., Lutz P., Isselbacher K.J., Bernards R.;
"Structure and expression of MBP-2: a 275 kDa zinc finger protein that
binds to an enhancer of major histocompatibility complex class 1
genes.";
Proc. Natl. Acad. Sci. U.S.A. 89:8971-8975(1992).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-1538.
Kukita Y., Komiya T., Tahira T., Asakawa S., Shimizu N., Suzuki Y.,
Sugano S., Hayashi K.;
"Characterization of the human MBP-2/HIV-EP2 gene: identification of
multiple promoters and alternative splicing of 5' untranslated
region.";
Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=14574404; DOI=10.1038/nature02055;
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
"The DNA sequence and analysis of human chromosome 6.";
Nature 425:805-811(2003).
[5]
NUCLEOTIDE SEQUENCE [MRNA] OF 1797-1936.
PubMed=2247438; DOI=10.1073/pnas.87.22.8707;
Rustgi A.K., Van't Veer L.J., Bernards R.;
"Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding
properties.";
Proc. Natl. Acad. Sci. U.S.A. 87:8707-8710(1990).
[6]
TISSUE SPECIFICITY.
TISSUE=Brain;
PubMed=10207097; DOI=10.1128/MCB.19.5.3736;
Doerflinger U., Pscherer A., Moser M., Ruemmele P., Schuele R.,
Buettner R.;
"Activation of somatostatin receptor II expression by transcription
factors MIBP1 and SEF-2 in the murine brain.";
Mol. Cell. Biol. 19:3736-3747(1999).
[7]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Leukemic T-cell;
PubMed=19690332; DOI=10.1126/scisignal.2000007;
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
Rodionov V., Han D.K.;
"Quantitative phosphoproteomic analysis of T cell receptor signaling
reveals system-wide modulation of protein-protein interactions.";
Sci. Signal. 2:RA46-RA46(2009).
[8]
INVOLVEMENT IN MRD43.
PubMed=23020937; DOI=10.1016/S0140-6736(12)61480-9;
Rauch A., Wieczorek D., Graf E., Wieland T., Endele S.,
Schwarzmayr T., Albrecht B., Bartholdi D., Beygo J., Di Donato N.,
Dufke A., Cremer K., Hempel M., Horn D., Hoyer J., Joset P.,
Roepke A., Moog U., Riess A., Thiel C.T., Tzschach A., Wiesener A.,
Wohlleber E., Zweier C., Ekici A.B., Zink A.M., Rump A., Meisinger C.,
Grallert H., Sticht H., Schenck A., Engels H., Rappold G.,
Schroeck E., Wieacker P., Riess O., Meitinger T., Reis A., Strom T.M.;
"Range of genetic mutations associated with severe non-syndromic
sporadic intellectual disability: an exome sequencing study.";
Lancet 380:1674-1682(2012).
[9]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=22814378; DOI=10.1073/pnas.1210303109;
Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
Aldabe R.;
"N-terminal acetylome analyses and functional insights of the N-
terminal acetyltransferase NatB.";
Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2118; SER-2297 AND
SER-2301, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[11]
INVOLVEMENT IN MRD43.
PubMed=26153216; DOI=10.1038/ejhg.2015.151;
Srivastava S., Engels H., Schanze I., Cremer K., Wieland T.,
Menzel M., Schubach M., Biskup S., Kreiss M., Endele S., Strom T.M.,
Wieczorek D., Zenker M., Gupta S., Cohen J., Zink A.M., Naidu S.;
"Loss-of-function variants in HIVEP2 are a cause of intellectual
disability.";
Eur. J. Hum. Genet. 24:556-561(2016).
-!- FUNCTION: This protein specifically binds to the DNA sequence 5'-
GGGACTTTCC-3' which is found in the enhancer elements of numerous
viral promoters such as those of SV40, CMV, or HIV1. In addition,
related sequences are found in the enhancer elements of a number
of cellular promoters, including those of the class I MHC,
interleukin-2 receptor, somatostatin receptor II, and interferon-
beta genes. It may act in T-cell activation.
-!- SUBUNIT: Interacts with TCF4. {ECO:0000250}.
-!- SUBCELLULAR LOCATION: Nucleus.
-!- TISSUE SPECIFICITY: Expressed in brain and skeletal muscle.
{ECO:0000269|PubMed:10207097}.
-!- INDUCTION: By mitogens and phorbol ester.
-!- DISEASE: Mental retardation, autosomal dominant 43 (MRD43)
[MIM:616977]: A form of mental retardation, a disorder
characterized by significantly below average general intellectual
functioning associated with impairments in adaptive behavior and
manifested during the developmental period. MRD43 patients
manifest developmental delay, intellectual disability, hypotonia,
and dysmorphic features. {ECO:0000269|PubMed:23020937,
ECO:0000269|PubMed:26153216}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SEQUENCE CAUTION:
Sequence=AAB88218.1; Type=Erroneous initiation; Evidence={ECO:0000305};
Sequence=CAA46596.1; Type=Erroneous initiation; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; M60119; AAB88218.1; ALT_INIT; Genomic_DNA.
EMBL; X65644; CAA46596.1; ALT_INIT; mRNA.
EMBL; AF153836; AAF81365.1; -; Genomic_DNA.
EMBL; AL023584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; M61744; AAA36202.1; -; mRNA.
CCDS; CCDS43510.1; -.
PIR; S26661; WMHUE2.
RefSeq; NP_006725.3; NM_006734.3.
RefSeq; XP_016866294.1; XM_017010805.1.
UniGene; Hs.510172; -.
ProteinModelPortal; P31629; -.
BioGrid; 109344; 9.
IntAct; P31629; 14.
MINT; MINT-7027293; -.
STRING; 9606.ENSP00000012134; -.
iPTMnet; P31629; -.
PhosphoSitePlus; P31629; -.
BioMuta; HIVEP2; -.
DMDM; 83305815; -.
EPD; P31629; -.
MaxQB; P31629; -.
PaxDb; P31629; -.
PeptideAtlas; P31629; -.
PRIDE; P31629; -.
DNASU; 3097; -.
Ensembl; ENST00000012134; ENSP00000012134; ENSG00000010818.
Ensembl; ENST00000367603; ENSP00000356575; ENSG00000010818.
Ensembl; ENST00000367604; ENSP00000356576; ENSG00000010818.
GeneID; 3097; -.
KEGG; hsa:3097; -.
UCSC; uc003qjd.4; human.
CTD; 3097; -.
DisGeNET; 3097; -.
GeneCards; HIVEP2; -.
H-InvDB; HIX0032889; -.
HGNC; HGNC:4921; HIVEP2.
HPA; HPA055954; -.
MIM; 143054; gene.
MIM; 616977; phenotype.
neXtProt; NX_P31629; -.
OpenTargets; ENSG00000010818; -.
PharmGKB; PA29298; -.
eggNOG; KOG1721; Eukaryota.
eggNOG; COG5048; LUCA.
GeneTree; ENSGT00530000063161; -.
HOGENOM; HOG000155774; -.
HOVERGEN; HBG007119; -.
InParanoid; P31629; -.
KO; K09239; -.
OMA; RKKCFLV; -.
OrthoDB; EOG091G004W; -.
PhylomeDB; P31629; -.
TreeFam; TF331837; -.
GeneWiki; HIVEP2; -.
GenomeRNAi; 3097; -.
PRO; PR:P31629; -.
Proteomes; UP000005640; Chromosome 6.
Bgee; ENSG00000010818; -.
CleanEx; HS_HIVEP2; -.
Genevisible; P31629; HS.
GO; GO:0005654; C:nucleoplasm; IDA:HPA.
GO; GO:0005634; C:nucleus; IBA:GO_Central.
GO; GO:0003677; F:DNA binding; TAS:UniProtKB.
GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
GO; GO:0043565; F:sequence-specific DNA binding; IBA:GO_Central.
GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IBA:GO_Central.
GO; GO:0044212; F:transcription regulatory region DNA binding; IBA:GO_Central.
GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
GO; GO:0007165; P:signal transduction; IBA:GO_Central.
GO; GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GO_Central.
Gene3D; 3.30.40.10; -; 1.
InterPro; IPR013087; Znf_C2H2_type.
InterPro; IPR013083; Znf_RING/FYVE/PHD.
SMART; SM00355; ZnF_C2H2; 4.
SUPFAM; SSF57667; SSF57667; 2.
PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
1: Evidence at protein level;
Complete proteome; DNA-binding; Mental retardation; Metal-binding;
Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
Transcription; Transcription regulation; Zinc; Zinc-finger.
CHAIN 1 2446 Transcription factor HIVEP2.
/FTId=PRO_0000047371.
REPEAT 2053 2056 1.
REPEAT 2059 2062 2.
REPEAT 2071 2074 3.
REPEAT 2083 2086 4.
REPEAT 2089 2092 5.
REPEAT 2106 2109 6.
REPEAT 2112 2115 7.
REPEAT 2118 2121 8.
REPEAT 2130 2133 9.
REPEAT 2145 2148 10.
ZN_FING 189 211 C2H2-type 1. {ECO:0000255|PROSITE-
ProRule:PRU00042}.
ZN_FING 217 239 C2H2-type 2. {ECO:0000255|PROSITE-
ProRule:PRU00042}.
ZN_FING 1799 1821 C2H2-type 3. {ECO:0000255|PROSITE-
ProRule:PRU00042}.
ZN_FING 1827 1851 C2H2-type 4. {ECO:0000255|PROSITE-
ProRule:PRU00042}.
REGION 2053 2148 10 X 4 AA tandem repeats of S-P-[RGMKC]-
[RK].
MOTIF 937 943 Nuclear localization signal.
{ECO:0000255}.
COMPBIAS 950 982 Ser-rich.
COMPBIAS 1510 1586 Ser-rich.
COMPBIAS 1899 1923 Asp/Glu-rich (acidic).
COMPBIAS 2073 2148 Arg-rich.
MOD_RES 819 819 Phosphoserine.
{ECO:0000250|UniProtKB:Q00900}.
MOD_RES 950 950 Phosphoserine.
{ECO:0000250|UniProtKB:Q3UHF7}.
MOD_RES 955 955 Phosphoserine.
{ECO:0000250|UniProtKB:Q3UHF7}.
MOD_RES 1048 1048 Phosphoserine.
{ECO:0000250|UniProtKB:Q3UHF7}.
MOD_RES 1443 1443 Phosphoserine.
{ECO:0000250|UniProtKB:Q3UHF7}.
MOD_RES 1447 1447 Phosphoserine.
{ECO:0000250|UniProtKB:Q3UHF7}.
MOD_RES 2118 2118 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 2297 2297 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 2301 2301 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 2429 2429 Phosphoserine.
{ECO:0000250|UniProtKB:Q3UHF7}.
MOD_RES 2431 2431 Phosphoserine.
{ECO:0000250|UniProtKB:Q3UHF7}.
VARIANT 46 46 R -> Q (in dbSNP:rs17072013).
/FTId=VAR_052754.
VARIANT 1041 1041 A -> V (in dbSNP:rs34875559).
/FTId=VAR_052755.
VARIANT 1293 1293 L -> I (in dbSNP:rs35675714).
/FTId=VAR_052756.
VARIANT 1538 1538 L -> P (in dbSNP:rs109836).
{ECO:0000269|PubMed:1409593,
ECO:0000269|PubMed:2022670,
ECO:0000269|Ref.3}.
/FTId=VAR_052757.
CONFLICT 2091 2091 R -> T (in Ref. 2; CAA46596).
{ECO:0000305}.
SEQUENCE 2446 AA; 269053 MW; 482E2C577EF9449A CRC64;
MDTGDTALGQ KATSRSGETD KASGRWRQEQ SAVIKMSTFG SHEGQRQPQI EPEQIGNTAS
AQLFGSGKLA SPSEVVQQVA EKQYPPHRPS PYSCQHSLSF PQHSLPQGVM HSTKPHQSLE
GPPWLFPGPL PSVASEDLFP FPIHGHSGGY PRKKISSLNP AYSQYSQKSI EQAEEAHKKE
HKPKKPGKYI CPYCSRACAK PSVLKKHIRS HTGERPYPCI PCGFSFKTKS NLYKHRKSHA
HAIKAGLVPF TESAVSKLDL EAGFIDVEAE IHSDGEQSTD TDEESSLFAE ASDKMSPGPP
IPLDIASRGG YHGSLEESLG GPMKVPILII PKSGIPLPNE SSQYIGPDML PNPSLNTKAD
DSHTVKQKLA LRLSEKKGQD SEPSLNLLSP HSKGSTDSGY FSRSESAEQQ ISPPNTNAKS
YEEIIFGKYC RLSPRNALSV TTTSQERAAM GRKGIMEPLP HVNTRLDVKM FEDPVSQLIP
SKGDVDPSQT SMLKSTKFNS ESRQPQIIPS SIRNEGKLYP ANFQGSNPVL LEAPVDSSPL
IRSNSVPTSS ATNLTIPPSL RGSHSFDERM TGSDDVFYPG TVGIPPQRML RRQAAFELPS
VQEGHVEVEH HGRMLKGISS SSLKEKKLSP GDRVGYDYDV CRKPYKKWED SETPKQNYRD
ISCLSSLKHG GEYFMDPVVP LQGVPSMFGT TCENRKRRKE KSVGDEEDTP MICSSIVSTP
VGIMASDYDP KLQMQEGVRS GFAMAGHENL SHGHTERFDP CRPQLQPGSP SLVSEESPSA
IDSDKMSDLG GRKPPGNVIS VIQHTNSLSR PNSFERSESA ELVACTQDKA PSPSETCDSE
ISEAPVSPEW APPGDGAESG GKPSPSQQVQ QQSYHTQPRL VRQHNIQVPE IRVTEEPDKP
EKEKEAQSKE PEKPVEEFQW PQRSETLSQL PAEKLPPKKK RLRLADMEHS SGESSFESTG
TGLSRSPSQE SNLSHSSSFS MSFEREETSK LSALPKQDEF GKHSEFLTVP AGSYSLSVPG
HHHQKEMRRC SSEQMPCPHP AEVPEVRSKS FDYGNLSHAP VSGAAASTVS PSRERKKCFL
VRQASFSGSP EISQGEVGMD QSVKQEQLEH LHAGLRSGWH HGPPAVLPPL QQEDPGKQVA
GPCPPLSSGP LHLAQPQIMH MDSQESLRNP LIQPTSYMTS KHLPEQPHLF PHQETIPFSP
IQNALFQFQY PTVCMVHLPA QQPPWWQAHF PHPFAQHPQK SYGKPSFQTE IHSSYPLEHV
AEHTGKKPAE YAHTKEQTYP CYSGASGLHP KNLLPKFPSD QSSKSTETPS EQVLQEDFAS
ANAGSLQSLP GTVVPVRIQT HVPSYGSVMY TSISQILGQN SPAIVICKVD ENMTQRTLVT
NAAMQGIGFN IAQVLGQHAG LEKYPIWKAP QTLPLGLESS IPLCLPSTSD SVATLGGSKR
MLSPASSLEL FMETKQQKRV KEEKMYGQIV EELSAVELTN SDIKKDLSRP QKPQLVRQGC
ASEPKDGLQS GSSSFSSLSP SSSQDYPSVS PSSREPFLPS KEMLSGSRAP LPGQKSSGPS
ESKESSDELD IDETASDMSM SPQSSSLPAG DGQLEEEGKG HKRPVGMLVR MASAPSGNVA
DSTLLLTDMA DFQQILQFPS LRTTTTVSWC FLNYTKPNYV QQATFKSSVY ASWCISSCNP
NPSGLNTKTT LALLRSKQKI TAEIYTLAAM HRPGTGKLTS SSAWKQFTQM KPDASFLFGS
KLERKLVGNI LKERGKGDIH GDKDIGSKQT EPIRIKIFEG GYKSNEDYVY VRGRGRGKYI
CEECGIRCKK PSMLKKHIRT HTDVRPYVCK LCNFAFKTKG NLTKHMKSKA HMKKCLELGV
SMTSVDDTET EEAENLEDLH KAAEKHSMSS ISTDHQFSDA EESDGEDGDD NDDDDEDEDD
FDDQGDLTPK TRSRSTSPQP PRFSSLPVNV GAVPHGVPSD SSLGHSSLIS YLVTLPSIRV
TQLMTPSDSC EDTQMTEYQR LFQSKSTDSE PDKDRLDIPS CMDEECMLPS EPSSSPRDFS
PSSHHSSPGY DSSPCRDNSP KRYLIPKGDL SPRRHLSPRR DLSPMRHLSP RKEAALRREM
SQRDVSPRRH LSPRRPVSPG KDITARRDLS PRRERRYMTT IRAPSPRRAL YHNPPLSMGQ
YLQAEPIVLG PPNLRRGLPQ VPYFSLYGDQ EGAYEHPGSS LFPEGPNDYV FSHLPLHSQQ
QVRAPIPMVP VGGIQMVHSM PPALSSLHPS PTLPLPMEGF EEKKGASGES FSKDPYVLSK
QHEKRGPHAL QSSGPPSTPS SPRLLMKQST SEDSLNATER EQEENIQTCT KAIASLRIAT
EEAALLGPDQ PARVQEPHQN PLGSAHVSIR HFSRPEPGQP CTSATHPDLH DGEKDNFGTS
QTPLAHSTFY SKSCVDDKQL DFHSSKELSS STEESKDPSS EKSQLH


Related products :

Catalog number Product name Quantity
EIAAB47036 Hivep2,Human immunodeficiency virus type I enhancer-binding protein 2 homolog,Mibp1,MIBP-1,Mouse,Mus musculus,Myc intron-binding protein 1,Transcription factor HIVEP2
EIAAB47035 HIVEP2,HIV-EP2,Homo sapiens,Human,Human immunodeficiency virus type I enhancer-binding protein 2,MBP-2,MHC-binding protein 2,Transcription factor HIVEP2
EIAAB47034 Agie-bp1,Angiotensinogen gene-inducible enhancer-binding protein 1,DNA-binding protein AGIE-BP1,Hivep2,Human immunodeficiency virus type I enhancer-binding protein 2 homolog,Mibp1,MIBP-1,Myc intron-bi
HJCD HIVEP2 Gene human immunodeficiency virus type I enhancer binding protein 2
CSB-EL010465RA Rat human immunodeficiency virus type I enhancer binding protein 2 (HIVEP2) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL010465HU Human human immunodeficiency virus type I enhancer binding protein 2 (HIVEP2) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL010465MO Mouse human immunodeficiency virus type I enhancer binding protein 2 (HIVEP2) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
EIAAB47038 Hivep3,Human immunodeficiency virus type I enhancer-binding protein 3 homolog,Kappa-B and V(D)J recombination signal sequences-binding protein,Kappa-binding protein 1,KB-binding and regognition compon
EIAAB47037 HIVEP3,Homo sapiens,Human,Human immunodeficiency virus type I enhancer-binding protein 3,Kappa-B and V(D)J recombination signal sequences-binding protein,Kappa-binding protein 1,KBP1,KBP-1,KIAA1555,KR
HIVEP3 HIVEP1 Gene human immunodeficiency virus type I enhancer binding protein 1
HJURP HIVEP3 Gene human immunodeficiency virus type I enhancer binding protein 3
EIAAB46626 CBF-A,CCAAT-binding transcription factor I subunit A,DBPB,DNA-binding protein B,EFI-A,Enhancer factor I subunit A,Homo sapiens,Human,NSEP1,Nuclease-sensitive element-binding protein 1,YB1,YB-1,Y-box t
EIAAB47032 Cirhin interaction protein,CIRIP,GAAP,Gate keeper of apoptosis-activating protein,HIVEP1,HIV-EP1,Homo sapiens,Human,Human immunodeficiency virus type I enhancer-binding protein 1,Major histocompatibil
EIAAB47067 Alpha-fetoprotein enhancer-binding protein,AT motif-binding factor,ATBF1,AT-binding transcription factor 1,Homo sapiens,Human,ZFH-3,ZFHX3,Zinc finger homeobox protein 3,Zinc finger homeodomain protein
18-003-42521 Nuclease sensitive element-binding protein 1 - Y-box-binding protein 1; Y-box transcription factor; YB-1; CCAAT-binding transcription factor I subunit A; CBF-A; Enhancer factor I subunit A; EFI-A; DNA 0.05 mg Aff Pur
20-372-60120 transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) - Mouse monoclonal anti-human TFAP2A antibody; AP2-alpha; Activating enhancer-binding protein 2 alpha; AP-2 transcription 0.1 mg
CSB-EL010466HU Human human immunodeficiency virus type I enhancer binding protein 3 (HIVEP3) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL010464HU Human human immunodeficiency virus type I enhancer binding protein 1 (HIVEP1) ELISA kit, Species Human, Sample Type serum, plasma 96T
EIAAB46625 CBF-A,CCAAT-binding transcription factor I subunit A,DBPB,DNA-binding protein B,EFI-A,Enhancer factor I subunit A,Mouse,Msy1,Msy-1,Mus musculus,Nsep1,Nuclease-sensitive element-binding protein 1,Yb1,Y
EIAAB46627 Bos taurus,Bovine,CBF-A,CCAAT-binding transcription factor I subunit A,DBPB,DNA-binding protein B,EFI-A,Enhancer factor I subunit A,NSEP1,Nuclease-sensitive element-binding protein 1,YB1,YB-1,Y-box tr
EIAAB46624 CBF-A,CCAAT-binding transcription factor I subunit A,DBPB,DNA-binding protein B,EFI-A,Enhancer factor I subunit A,Msy-1,Nsep1,Nuclease-sensitive element-binding protein 1,Rat,Rattus norvegicus,Yb1,YB-
20-372-60290 transcription factor AP-4 (activating enhancer binding protein 4) - Mouse monoclonal anti-human TFAP4 antibody; Activating enhancer-binding protein 4 Monoclonal 0.1 mg
EIAAB47066 Alpha-fetoprotein enhancer-binding protein,AT motif-binding factor,Atbf1,AT-binding transcription factor 1,Mouse,Mus musculus,ZFH-3,Zfhx3,Zinc finger homeobox protein 3,Zinc finger homeodomain protein
CSB-EL010466MO Mouse human immunodeficiency virus type I enhancer binding protein 3 (HIVEP3) ELISA kit, Species Mouse, Sample Type serum, plasma 96T
CSB-EL010464MO Mouse human immunodeficiency virus type I enhancer binding protein 1 (HIVEP1) ELISA kit, Species Mouse, Sample Type serum, plasma 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur